Literature DB >> 168088

Papaverine, cyclic AMP and the dependence of the rat aorta on extracellular calcium.

F Demesy-Waeldele, J C Stoclet.   

Abstract

The spasmolytic effects of papaverine and dibutyryl cyclic AMP (db-cAMP) were compared on isometric contractile responses induced by addition of increasing amounts of external calcium to K+-depolarized or noradrenaline-stimulated rat aorta strips. Papaverine at a concentration active on depolarized strips (3 times 10(-5) moles/1) reduced the maximal contraction (Emax) elicited by Ca2+ in these preparations, while db-cAMP did not. Contrary to what was observed on depolarized aortae, the degree of inhibition of noradrenaline-stimulated strips did not decrease with increasing extracellular calcium concentration (Ca)e. Both db-cAMP and papaverine at a concentration which did not depress Emax (5 times 10(-6) moles/1) potentiated the relaxing effect of high (Ca)e on contractions elicited by noradrenaline. In conclusion, cyclic AMP is probably implicated in the mode of action of papaverine on the noradrenaline-stimulated rat aorta. At a concentration active on depolarized strips, papaverine is also able to impair contractility directly.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168088     DOI: 10.1016/0014-2999(75)90039-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Effect of parathyroidectomy on cardiovascular reactivity in rats with mineralocorticoid-induced hypertension.

Authors:  A Berthelot; A Gairard
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

2.  Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase.

Authors:  G Pöch; W Umfahrer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

3.  Methylflavonolamine hydrochloride inhibits contractions induced by noradrenaline, calcium and potassium in rabbit isolated aortic strips.

Authors:  M S Zhang; E F Zhou
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.